Malonic acid
|
Basic information |
| Metabolite name | Malonic acid |
 | HMDB0000691 |
 |
C00383 |
 |
867 |
| Synonyms | Dimethylmalonic acid; |
| No. of studies | 19 |
|
Basic information |
| Metabolite name | Malonic acid |
| HMDB0000691 |
|
C00383 |
|
867 |
| Synonyms | Dimethylmalonic acid; |
| No. of studies | 19 |
|
Relationship between Malonic acid and depression (count: 19) |
| Study | Study Type  |
Comparison groups | Tissue | Organism | Up/Down regulated |
| Study M036 | Type1 | MDD group vs. control group | Urine | Human | Down |
| Study M043 | Type1 | chronic hepatitis B patients with MDD group vs. without MDD group | Urine | Human | Down |
| Study M058 | Type1 | depressed HBV-infected patients group vs. control group and non-depressed HBV-infected group | Urine | Human | Down |
| Study M097 | Type1 | depressed women group vs. control women group | Urine | Human | Down |
| Study M098 | Type1 | depressed group vs. control group | Peripheral blood mononuclear cell | Human | Down |
| Study M102 | Type1 | moderate MDD group vs. control group | Urine | Human | Down |
| Study M102 | Type1 | severe MDD group vs. control group | Urine | Human | Down |
| Study M1072 | Type1 | CUMS group vs. control group | Plasma | Cynomolgus monkey | Down |
| Study M1140 | Type1 | CUMS group vs. control group | Serum | Sprague-Dawley rat | Down |
| Study M181 | Type3 | venlafaxine group vs. control group | Hippocampus | Sprague-Dawley rat | Up |
| Study M463 | Type3 | DG group vs. control group | Prefrontal cortex | C57BL/6J mouse | Up |
| Study M463 | Type3 | venlafaxine group vs. control group | Prefrontal cortex | C57BL/6J mouse | Down |
| Study M492 | Type1 | ACTH group vs. control group | Urine | Wistar rat | Down |
| Study M492 | Type2 | ACTH + CGA group vs. ACTH group | Urine | Wistar rat | Up |
| Study M492 | Type2 | ACTH + memantine group vs. ACTH group | Urine | Wistar rat | Up |
| Study M536 | Type1 | naturally-occurring depression group vs. control group | Cerebrospinal fluid | Cynomolgus monkey | Up |
| Study M613 | Type1 | CSDS susceptible group vs. control group | Serum | C57BL/6 J mouse | Down |
| Study M614 | Type1 | CUMS group vs. control group | Urine | Sprague-Dawley rat | Down |
| Study M630 | Type2 | acupuncture + antidepressant group, post vs. before treatment | Urine | Human | Down |
| Study M663 | Type3 | diterpene ginkgolides group vs. control group | Prefrontal cortex | Sprague-Dawley rat | Up |
| Study M749 | Type1 | CUMS group vs. control group | Plasma | Cynomolgus monkey | Down |
| Study M943 | Type1 | CUMS group vs. control group | Liver | ICR mouse | Up |
| Study M953 | Type1 | CRS group vs. control group | Faece | Sprague-Dawley rat | Up |
| Study M953 | Type2 | CRS + Shugan Granule group vs. CRS group | Faece | Sprague-Dawley rat | Down |